(Q39710940)

14 September 2017

1 reference

title

Complement: a host defense mechanism ready for pharmacological manipulation? (English)

1 reference

14 September 2017

Complement: A Host Defense Mechanism Ready for Pharmacological Manipulation? (English)

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

27 March 2023

main subject

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

27 March 2023

author name string

B. J. Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336865

27 March 2023

language of work or name

English

0 references

publication date

1 October 1977

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0022354915396234?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

https://api.elsevier.com/content/article/PII:S0022354915396234?httpAccept=text/plain

27 March 2023

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Journal of Pharmaceutical Sciences

27 March 2023

published in

1 reference

14 September 2017

volume

66

1 reference

14 September 2017

issue

10

1 reference

14 September 2017

page(s)

1367-1377

1 reference

The separation of nine components and two inactivators of components of component in human serum

14 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

C1r, subunit of the first complement component: purification, properties, and assay based on its linking role

27 March 2023

3

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT

27 March 2023

5

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase

27 March 2023

6

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

27 March 2023

7

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Isolation of the sixth component of complement from human serum.

27 March 2023

8

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency

27 March 2023

10

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The human complement system

27 March 2023

12

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The reaction of monomeric and aggregated immunoglobulins with C1.

27 March 2023

13

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten

27 March 2023

15

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Cleavage of the fourth component of human complement (C4) by activated activated Cls

27 March 2023

17

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Cleavage of the fourth component of human complement (C4) by C1 esterase: Isolation and characterization of the low molecular weight product

27 March 2023

18

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Reversible adsorption of C′2 by EAC′4: Role of Mg2+, enumeration of competent SAC′4, two-step nature of C′2a fixation and estimation of its efficiency

27 March 2023

19

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Catalysis of C'2 fixation by C'la. Reaction kinetics, competitive inhibition by TAMe, and transferase hypothesis of the enzymatic action of C'la on C'2, one of its natural substrates

27 March 2023

20

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

C'2ad, an inactive derivative of C'2 released during decay of EAC'4,2a

27 March 2023

21

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

A fragment of the third component of human complement with anaphylatoxin activity.

27 March 2023

22

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Anaphylatoxin in its relation to the complement system

27 March 2023

26

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

27 March 2023

27

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera

27 March 2023

33

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Insulin and IgG Complexes: An Immunologic Bypass for Complement Activation

27 March 2023

36

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena

27 March 2023

38

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The properdin system and immunity. III. The zymosan assay of properdin

27 March 2023

39

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Properdin system and immunity. II. Interaction of the properdin system with polysaccharides

27 March 2023

40

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum

27 March 2023

43

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

C3 proactivator convertase and its mode of action

27 March 2023

44

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens

27 March 2023

46

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components

27 March 2023

47

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunoglobulin Peptide with Complement Fixing Activity

27 March 2023

57

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

A fragment corresponding to the C(H)2 region of immunoglobulin G (IgG) with complement fixing activity

27 March 2023

58

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

SNAKE VENOM IN RELATION TO HAEMOLYSIS, BACTERIOLYSIS, AND TOXICITY.

27 March 2023

60

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement

27 March 2023

67

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Formation and function of a complex of the C3 proactivator with a protein from cobra venom

27 March 2023

69

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

[Isolation and properties of a beta-glycoprotein from human serum]

27 March 2023

71

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Isolation and properties of a glycine-rich β-glycoprotein of human serum

27 March 2023

72

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Properdin factor D: characterization of its active site and isolation of the precursor form

27 March 2023

76

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B

27 March 2023

80

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

27 March 2023

81

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)

27 March 2023

82

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The conversion of C'IS to C'1 esterase by plasmin and trypsin

27 March 2023

83

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

A plasmin-split fragment of C'3 as a new chemotactic factor

27 March 2023

87

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement

27 March 2023

88

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement

27 March 2023

89

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

C3 leukotactic factors produced by a tissue protease

27 March 2023

90

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Journal of Clinical Investigation

27 March 2023

92

48

44a

Klemperer

1969

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization

27 March 2023

94

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3

27 March 2023

95

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement

27 March 2023

96

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes

27 March 2023

97

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum

27 March 2023

98

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO

27 March 2023

102

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization

27 March 2023

103

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

27 March 2023

104

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE

27 March 2023

105

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. II. Acute, subacute, and chronic glomerulonephritis

27 March 2023

107

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The localization of in vivo bound complement in tissue section

27 March 2023

108

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients

27 March 2023

109

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement in human disease

27 March 2023

112

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

27 March 2023

113

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus

27 March 2023

114

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunopathologic studies of systemic lupus erythematosus (SLE). I. Tissue-bound immunoglobulins in relation to serum antinuclear immunoglobulins in systemic lupus and in chronic liver disease with LE cell factor

27 March 2023

115

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

An immunofluorescent study of the skin lesions in systemic lupus erythematosus

27 March 2023

116

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunological studies concerning the nephritis of systemic lupus erythematosus

27 March 2023

117

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis

27 March 2023

118

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

TOTAL HEMOLYTIC COMPLEMENT (CH50) AND SECOND COMPONENT OF COMPLEMENT (C2 HU) ACTIVITY IN SERUM AND SYNOVIAL FLUID.

27 March 2023

121

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

STUDIES ON THE DEPRESSED HEMOLYTIC COMPLEMENT ACTIVITY OF SYNOVIAL FLUID IN ADULT RHEUMATOID ARTHRITIS

27 March 2023

122

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation

27 March 2023

129

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).

27 March 2023

131

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Allograft rejection in C'6 defective rabbits

27 March 2023

136

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Some properties of an esterase derived from preparations of the first component of complement

27 March 2023

137

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Assay and Properties of Serum Inhibitor of C'1-Esterase

27 March 2023

138

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r

27 March 2023

139

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

27 March 2023

140

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

27 March 2023

142

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)

27 March 2023

147

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

27 March 2023

148

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Inhibition of immune hemolysis by diisopropyl fluorophosphate

27 March 2023

156

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Irreversible enzyme inhibitors. CLIII. Proteolytic enzymes. 11. Inhibition of guinea pig complement by substituted phenoxyacetamides

27 March 2023

159

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Irreversible enzyme inhibitors. CLXI. Proteolytic enzymes. 13. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides. II.

27 March 2023

160

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Irreversible enzyme inhibitors. 180. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy) benzamidine and phenoxyacetamide

27 March 2023

161

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Catalysis of C'2 fixation by C'la. Reaction kinetics, competitive inhibition by TAMe, and transferase hypothesis of the enzymatic action of C'la on C'2, one of its natural substrates

27 March 2023

162

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Nature of the active site of a subunit of the first component of human complement

27 March 2023

163

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Inactivation of the first component of human complement by m-(o-(2-chloro-5-fluorosulfonylphenylureido)-phenoxybutoxy)benzamidine

27 March 2023

164

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

BIOLOGIC PROPERTIES OF POLYNUCLEOTIDES. I. THE ANTICOMPLEMENTARY ACTIVITY OF POLYNUCLEOTIDES

27 March 2023

186

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4

27 March 2023

188

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--II. Effect of polyanions on the binding of C2 to EAC4b

27 March 2023

189

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Studies on the complement-binding site of rabbit immunoglobulin G—I. Modification of tryptophan residues and their role in anticomplementary activity of rabbit IgG

27 March 2023

191

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Studies on the complement-binding site of rabbit immunoglobulin G—II. The reaction of rabbit IgG and its fragments with Clq

27 March 2023

192

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Structural Basis of the A14 and A15 Allotypic Specificities in Rabbit Immunoglobulin G

27 March 2023

193

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Stepwise cleavage of rabbit immunoglobulin G by papain and isolation of four types of biologically active Fc fragments

27 March 2023

194

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Amino acid sequence of a murine immunoglobulin fragment that possesses complement fixing activity

27 March 2023

197

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Polarization of the fluorescence of macromolecules. I. Theory and experimental method

27 March 2023

198

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Fluorescence depolarization of rabbit gamma globulin conjugates

27 March 2023

199

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Fluorescence polarization of human gamma-G-immunoglobulins.

27 March 2023

200

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Enzymic and immunochemical properties of lysozyme. I. Derivatives modified at tyrosine. Influence of nature of modification on activity

27 March 2023

201

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Modification of arginine in the active sites of antibodies

27 March 2023

202

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement fixing site of human IgG1

27 March 2023

203

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

The covalent structure of an entire gammaG immunoglobulin molecule

27 March 2023

204

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Primary structure of the CH2 homology region from guinea pig IgG2 antibodies

27 March 2023

205

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complete Amino Acid Sequence of the Mu Heavy Chain of a Human IgM Immunoglobulin

27 March 2023

207

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Synthesis, structure, and biological properties of sequential polypeptides

27 March 2023

210

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunologic reactions and periodontal inflammation

27 March 2023

211

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunological Mechanisms of Periodontal Tissue Destruction

27 March 2023

212

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Antibody-Mediated Effects on the Periodontium

27 March 2023

213

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Complement factors in gingival crevice material from healthy and inflamed gingiva in humans

27 March 2023

214

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Detection of Functional Complement Components in Gingival Crevicular Fluid from Humans with Periodontal Disease

27 March 2023

215

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunochemical comparison of proteins in human gingival pocket fluid, serum and saliva.

27 March 2023

216

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

Immunoglobulins and complement in crevicular fluid, serum and saliva in man

27 March 2023

217

1 reference

https://api.crossref.org/works/10.1002/JPS.2600661005

27 March 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=336865

27 March 2023

1 reference